Summary
Activity (Vmax) of monoamine oxidase (MAO) B in necrosy samples from the head of the caudate nucleus was 260% higher in patients dying with Huntington's disease (HD) than in controls (P<0.05). No differences in MAO A enzyme kinetics were found. MAO B, but not MAO A, was increased (26%) in the frontal cortex from patients dying with HD compared to control subjects. MAO A and B kinetics in caudate nucleus and frontal cortex from a group of schizophrenics did not differ from controls. Postmortem delay, the effect of neuroleptics, or nonspecific degeneration artifacts did not explain these findings. It is suggested that the increase in MAO B activity in the caudate nucleus may reflect neurochemical changes that are responsible for the choreiform movements of Huntington's disease. Lower cortical MAO B activity in the schizophrenic group may reflect the effects of neuroleptics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belendiuk, K., Belendiuk, G. W., Freedman, D. X.: Blood monoamine metabolism in Huntington's disease. Arch. Gen. Psychiat.37, 325–332 (1980).
Bird, E. D., Iversen, L. L.: Huntington's chorea: postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain97, 457–472 (1974).
Bird, E. D., Mackay, A. V., Rayner, C. N., Iversen L. L.: Reduced glutamic acid decarboxylase activity or postmortem brain in Huntington's chorea. Lanceti, 1090–1092 (1973).
Bird, E. D., Spokes, E. G.: Huntington's chorea. In: Disorders of Neurohumoural Transmission (Crow, T.J., ed.). London: Academic Press. 1982.
Domino, E. F., Krause, R. R., Bowers, J.: Various enzymes involved with putative transmitters: regional distribution in the brain of decreased mentally normal, chronic schizophrenics or organic brain syndrome patients. Arch. Gen. Psychiatry29, 195–201 (1973).
Fowler, C.J., Carlsson, A., Winblad, B.: Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and nonschizophrenic psychotics. J. Neural Transm.52, 23–32 (1981).
Glover, V., Sandler, M., Owen, F., et al.: Dopamine is a monoamine oxidase B substrate in man. Nature265, 80–81 (1977).
Klawans, H. L., Rubovits, R.: Central cholinergic-anticholinergic antagonism in Huntington's disease. Neurology22, 107–116 (1972).
Lange, H., Thorner, G., Hopf, A., Schroder, K. F.: Morphometric studies of the neuropathological changes in choreic diseases. J. Neurol. Sci.28, 401–425 (1976).
Lowry, O. H., Rosebrough, N. J., Fan, A. L., Randall, R. J.: Protein measurement with the folin reagent. J. Biol. Chem.193, 265–275 (1951).
Mann, J. J., Chui, E.: Platelet monoamine oxidase in Huntington's chorea. J. Neurol. Neurosurg. Psychiat.41, 809–812 (1978).
Mann, J. J., Stanley, M.: Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiat. Scand.69, 135–139 (1984).
Mann, J. J., Stanley, M., Kuster, J., Neophytides, A.: Elevated monoamine oxidase concentrations in brain and platelet tissue in Huntington's disease. In: Biological Psychiatry (Perris, C., Strewe, G., Jansson, B., eds.), pp. 410–414. Elsevier/North-Holland: Biomedical Press. 1981.
Mann, J. J., Stanley, M., Rossor, M., Gershon, S.: Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion. Science210, 1396–1371 (1980).
McGeer, P. L., McGeer, E. G.: Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J. Neurochem.26, 65–76 (1976).
Oreland, L., Fowler, C. J., Carlsson, A., Magnusson, T.: Monoamine oxidase-A and -B activity in rat brain after hemitransection. Life Sci.26, 139–146 (1980).
Reveley, M. A., Glover, V., Sandler, M., Spokes, E. G.: Brain monoamine oxidase activity in schizophrenics and controls. Arch. Gen. Psychiatry38, 663–665 (1981).
Robinson, D. S., Davis, J. M., Nies, A., Colburn, R. W., Davis, J. N., Bourne, H. R., Bunney, W. E., Shaw, D. M., Coppen, A.: Aging, monoamines and monoamine oxidase levels. Lanceti, 290–291 (1972).
Schwanz, M. A., Wyatt, R. J., Yung, H-Y. T., Nef N. H.: Multiple forms of brain monoamine oxidase in schizophrenics and normal individuals. Arch. Gen. Psychiat.31, 557–560 (1974).
Urquart, N., Perry, T. L., Hansen, S., Kennedy, J.: GABA content and glutamic acid decarboxylase activity in the brain of Huntington's chorea patients and control subjects. J. Neurochem.24, 1071–1075 (1975).
Walshe, F. X., Bird, E. D., Stevens, T.: Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain. In: Gilles de la Tourette Syndrome (Chase, T. N., Friedhoff, A. J., eds.), pp. 165–169. New York: Raven Press. 1982.
Winblad, B., Adolfsson, R., Gottfries, C. G., Oreland, L., Roos, B. E.: In: Recent Developments in Mass Spectrometry in Biochemistry and Medicine (Frigerio, A., ed.), Vol. 1, pp. 253–267. New York: Plenum. 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mann, J.J., Kaplan, R.D. & Bird, E.D. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in hUntington's disease compared to schizophrenics and controls. J. Neural Transmission 65, 277–283 (1986). https://doi.org/10.1007/BF01249088
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01249088